Colgate-Palmolive stock was up on the back of strong quarterly earnings.
Q4 2025 Management View Chairman, CEO & President Noel Wallace highlighted "stronger-than-expected Q4 results, and more importantly, our outlook for 2026, which marks the beginning of our new 2030 ...
Colgate-Palmolive swung to a loss in the fourth quarter, hurt by a large charge tied to its struggling skin-health business, ...
Jan 30 (Reuters) - Toothpaste maker Colgate-Palmolive forecast annual sales above Wall Street estimates on Friday, benefiting ...
Colgate-Palmolive Co. posted stronger-than-expected sales growth in the fourth quarter thanks to a rebound in Latin America ...
Thanks, and good morning, everyone, and thanks for joining us today as we discuss our stronger-than-expected Q4 results, and ...
JP Morgan analyst Andrea Teixeira maintained an Overweight rating and raised the price target from $88 to $93 on Jan. 16, 2026. This analyst has an accuracy rate of 60%. UBS analyst Peter Grom ...
"In the third quarter, our business saw a return to growth, driven by early positive signs in our core portfolio and ...
Colgate-Palmolive India reports Q3 net profit up 2.3% and sales up 1.4%, reflecting positive trends in core and premium ...
Q4 2025 Earnings Call January 30, 2026 8:30 AM ESTCompany ParticipantsJohn Faucher - Chief Investor Relations Officer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results